Literature DB >> 11451707

Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae.

A M Smith1, K P Klugman.   

Abstract

We report that alteration in MurM, an enzyme involved in the biosynthesis of branched-stem cell wall muropeptides, is required for maximal expression of penicillin and cefotaxime resistance in the pneumococcus. Hungarian isolate 3191 (penicillin MIC, 16 microg/ml; cefotaxime MIC, 4 microg/ml) was a source of donor DNA in transformation experiments. Penicillin-binding protein DNA was insufficient to transform recipient strain R6 to full resistance. Further transformation with altered murM DNA was required for full expression of donor penicillin and cefotaxime resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451707      PMCID: PMC90664          DOI: 10.1128/AAC.45.8.2393-2396.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae.

Authors:  R Muñoz; C G Dowson; M Daniels; T J Coffey; C Martin; R Hakenbeck; B G Spratt
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

2.  REGULATION OF THE TRANSFORMABILITY OF PHEUMOCOCCAL CULTURES BY MACROMOLECULAR CELL PRODUCTS.

Authors:  A TOMASZ; R D HOTCHKISS
Journal:  Proc Natl Acad Sci U S A       Date:  1964-03       Impact factor: 11.205

3.  Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

4.  Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action.

Authors:  P V Adrian; W Zhao; T A Black; K J Shaw; R S Hare; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

5.  Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa.

Authors:  A M Smith; K P Klugman; T J Coffey; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 6.  Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics.

Authors:  D J Waxman; J L Strominger
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  Penicillin-binding proteins of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae.

Authors:  S Zighelboim; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

8.  Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  G Laible; B G Spratt; R Hakenbeck
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

9.  Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  R Hakenbeck; M Tarpay; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

10.  A biological price of antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci.

Authors:  J Garcia-Bustos; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more
  33 in total

1.  Emergence of a pneumococcal clone with cephalosporin resistance and penicillin susceptibility.

Authors:  A M Smith; R F Botha; H J Koornhof; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 2.  FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci.

Authors:  S Rohrer; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

3.  In vivo penicillin MIC drift to extremely high resistance in Serotype 14 Streptococcus pneumoniae persistently colonizing the nasopharynx of an infant with chronic suppurative lung disease: a case study.

Authors:  Amanda J Leach; Peter S Morris; Heidi Smith-Vaughan; John D Mathews
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  Site-specific mutagenesis analysis of PBP 1A from a penicillin-cephalosporin-resistant pneumococcal isolate.

Authors:  Anthony M Smith; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

5.  Amino acid mutations essential to production of an altered PBP 2X conferring high-level beta-lactam resistance in a clinical isolate of Streptococcus pneumoniae.

Authors:  Anthony M Smith; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of beta-lactam resistance.

Authors:  Laurent Chesnel; Raphaël Carapito; Jacques Croizé; Otto Dideberg; Thierry Vernet; André Zapun
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Comparative antipneumococcal activities of sulopenem and other drugs.

Authors:  Klaudia Kosowska-Shick; Lois M Ednie; Pamela McGhee; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

8.  Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates.

Authors:  Fereshteh Fani; Philippe Leprohon; George G Zhanel; Michel G Bergeron; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

9.  A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae.

Authors:  Hansjürg Engel; Moana Mika; Dalia Denapaite; Regine Hakenbeck; Kathrin Mühlemann; Manfred Heller; Lucy J Hathaway; Markus Hilty
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

10.  Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Authors:  Mignon du Plessis; Edouard Bingen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.